NH THERAGUIX Trademark

Trademark Overview


On Friday, September 20, 2019, a trademark application was filed for NH THERAGUIX with the United States Patent and Trademark Office. The USPTO has given the NH THERAGUIX trademark a serial number of 79273896. The federal status of this trademark filing is REGISTERED as of Tuesday, January 19, 2021. This trademark is owned by NH THERAGUIX. The NH THERAGUIX trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical and veterinary products for the detection of tumours and the treatment of cancers; chemical preparations for medical or pharmaceutical use, particularly molecules, particles or medicines for imaging and radiotherapy for the detection of tumours and the treatment of cancer; chemical preparations for medical or pharmaceutical use, particularly nanomedicines, particles with therapeutic effect and new theranostic compounds for the detection of tumours and the treatment of cancer

Evaluations, estimates and research in scientific and technological fields carried out by engineers, particularly in the field of clinical trials of molecules, particles or medicines; research and development of nanomedicines, particles with therapeutic effect and new theranostic compounds
nh theraguix

General Information


Serial Number79273896
Word MarkNH THERAGUIX
Filing DateFriday, September 20, 2019
Status700 - REGISTERED
Status DateTuesday, January 19, 2021
Registration Number6247996
Registration DateTuesday, January 19, 2021
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 3, 2020

Trademark Statements


Goods and ServicesPharmaceutical and veterinary products for the detection of tumours and the treatment of cancers; chemical preparations for medical or pharmaceutical use, particularly molecules, particles or medicines for imaging and radiotherapy for the detection of tumours and the treatment of cancer; chemical preparations for medical or pharmaceutical use, particularly nanomedicines, particles with therapeutic effect and new theranostic compounds for the detection of tumours and the treatment of cancer
Goods and ServicesEvaluations, estimates and research in scientific and technological fields carried out by engineers, particularly in the field of clinical trials of molecules, particles or medicines; research and development of nanomedicines, particles with therapeutic effect and new theranostic compounds

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, December 16, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, December 16, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNH THERAGUIX
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressFR

Party NameNH THERAGUIX
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressFR

Party NameNH THERAGUIX
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressFR

Trademark Events


Event DateEvent Description
Thursday, December 12, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, December 16, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 19, 2019ASSIGNED TO EXAMINER
Friday, December 20, 2019APPLICATION FILING RECEIPT MAILED
Saturday, December 21, 2019NON-FINAL ACTION WRITTEN
Sunday, December 22, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, January 23, 2020NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Thursday, January 23, 2020NON-FINAL ACTION WRITTEN
Friday, January 24, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, February 19, 2020REFUSAL PROCESSED BY MPU
Thursday, February 20, 2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, March 7, 2020REFUSAL PROCESSED BY IB
Wednesday, August 19, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, September 11, 2020ASSIGNED TO LIE
Friday, September 11, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 11, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 24, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 14, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, October 14, 2020NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Tuesday, November 3, 2020PUBLISHED FOR OPPOSITION
Tuesday, November 3, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, November 25, 2020NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Saturday, December 12, 2020NOTIFICATION PROCESSED BY IB
Tuesday, January 19, 2021REGISTERED-PRINCIPAL REGISTER
Monday, April 19, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, April 23, 2021FINAL DISPOSITION PROCESSED
Friday, April 23, 2021FINAL DISPOSITION NOTICE SENT TO IB
Sunday, May 16, 2021FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, January 19, 2026COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED